Study details
Enrolling now
Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens
Argus Research Center, Inc.
NCT IDNCT07006428ClinicalTrials.gov data as of Apr 2026
Target enrollment
290
Study length
about 7 months
Ages
All ages
Locations
3 sites in CA, FL, GA
What this study is about
Researchers are testing the visual performance and patient satisfaction with two types of intraocular lenses (IOLs): Clareon PanOptix or a comparable multifocal IOL, in people with age-related cataracts. The trial will last for 207 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Clareon PanOptix or PanOptix Toric IOLs
- 2.Use Comparable multifocal IOL
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.